Back to search

Effects of ZD6474, an orally active inhibitor of VEGF receptor tyrosine kinase, in patients with solid tumors: Results from a phase I study

Scott N. Holden, S. Gail Eckhardt, R. Basser, Danny Rischin, Herbert I. Hurwitz
DOI: 10.1016/s0959-8049(01)80749-8
European Journal of Cancer

Data up to Jan 2025

Published2001
Citations2
References0
Fields
MedicineChemistryCancer researchInternal medicinePharmacology

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Effects of ZD6474, an orally active inhibitor of VEGF receptor tyrosine kinase, in… (2001) – European Journal of Cancer | Metascience Observatory Explorer